πŸ‡ΊπŸ‡Έ FDA
Patent

US 8664380

Heterocyclic compound and use thereof

granted A61PA61P13/12A61P43/00

Quick answer

US patent 8664380 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P13/12, A61P43/00, A61P9/00, A61P9/04